Indraprastha Medical Corporation Ltd.
NSE: INDRAMEDCO · Hospital
Snapshot
Unlock Indraprastha Medical Corporation Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indraprastha Medical Corporation Limited operates as a multi-speciality hospital provider based in New Delhi, India. The company offers a comprehensive range of medical services spanning over 40 clinical specialities, including advanced surgical procedures, transplant services, and diagnostic care.
Business Model
The company generates revenue primarily through the provision of inpatient and outpatient hospital services, diagnostic testing, and specialised surgical procedures. It operates through a network of healthcare facilities, including dedicated cosmetic and dental clinics.
Growth Outlook
Growth is expected to be driven by the increasing demand for specialised medical treatments and the expansion of advanced clinical services such as robotic and bariatric surgery. The company continues to focus on maintaining its position in the competitive healthcare market through service diversification.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Operational Risk. The hospital sector faces significant challenges in recruiting and retaining highly skilled medical professionals and nursing staff.
- Competitive Pressure. The company operates in a highly fragmented and competitive market, facing pressure from both large hospital chains and local healthcare providers.
- Medical Liability. Healthcare providers are inherently exposed to risks associated with medical negligence claims and potential litigation.
Start your research today
Unlock AI insights, financials, peers and live data on Indraprastha Medical Corporation Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,524 Cr
TTM · standalone
NET PROFIT
₹188 Cr
TTM · standalone
EPS
₹20.51
TTM · standalone
RETURN ON EQUITY
28.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
34.6%
TTM · standalone
P/E
17.1x
Q1 FY27 · standalone
EV/EBITDA
10.5x
Q1 FY27 · standalone
EBITDA MARGIN
19.9%
TTM · standalone
NET PROFIT MARGIN
13.8%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Hospital
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Indraprastha Medical Corporation Ltd.INDRAMEDCO | ₹3,206 Cr | 17.05 | 10.53 | 10.9% | 19.9% | 28.1% | 34.6% | -28.3% |
Dr Agarwals Eye Hospital LimitedDRAGARWQ | ₹2,621 Cr | — | — | — | 31.0% | — | — | +20.4% |
K M C Speciality Hospitals (India) LimitedKMCSHIL | ₹2,254 Cr | — | — | — | 29.0% | — | — | +103.4% |
Shalby Ltd.SHALBY | ₹1,649 Cr | 43.63 | 12.75 | 6.5% | 14.5% | 3.8% | 7.8% | -22.2% |
Gujarat Kidney And Super Speciality LimitedGKSL | ₹1,362 Cr | — | — | — | 33.0% | — | — | — |
Gpt Healthcare Ltd.GPTHEALTH | ₹1,298 Cr | 27.46 | 13.45 | 18.1% | 19.8% | 18.3% | 20.0% | +2.1% |
As of Q1 FY27
Financials
Indraprastha Medical Corporation Ltd.
NSE: INDRAMEDCO · Hospital
Snapshot
Unlock Indraprastha Medical Corporation Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Indraprastha Medical Corporation Limited operates as a multi-speciality hospital provider based in New Delhi, India. The company offers a comprehensive range of medical services spanning over 40 clinical specialities, including advanced surgical procedures, transplant services, and diagnostic care.
Business Model
The company generates revenue primarily through the provision of inpatient and outpatient hospital services, diagnostic testing, and specialised surgical procedures. It operates through a network of healthcare facilities, including dedicated cosmetic and dental clinics.
Growth Outlook
Growth is expected to be driven by the increasing demand for specialised medical treatments and the expansion of advanced clinical services such as robotic and bariatric surgery. The company continues to focus on maintaining its position in the competitive healthcare market through service diversification.
Key Risks
- Regulatory Risk. Changes in government healthcare policies or price caps on medical procedures and drugs could adversely impact profit margins.
- Operational Risk. The hospital sector faces significant challenges in recruiting and retaining highly skilled medical professionals and nursing staff.
- Competitive Pressure. The company operates in a highly fragmented and competitive market, facing pressure from both large hospital chains and local healthcare providers.
- Medical Liability. Healthcare providers are inherently exposed to risks associated with medical negligence claims and potential litigation.
Start your research today
Unlock AI insights, financials, peers and live data on Indraprastha Medical Corporation Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹1,524 Cr
TTM · standalone
NET PROFIT
₹188 Cr
TTM · standalone
EPS
₹20.51
TTM · standalone
RETURN ON EQUITY
28.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
34.6%
TTM · standalone
P/E
17.1x
Q1 FY27 · standalone
EV/EBITDA
10.5x
Q1 FY27 · standalone
EBITDA MARGIN
19.9%
TTM · standalone
NET PROFIT MARGIN
13.8%
Q1 FY27 · standalone
DEBT TO EQUITY
0.0x
Q1 FY27 · standalone
Peers · Hospital
As of Q1 FY27